FIELD: biotechnology, medicine. SUBSTANCE: live vaccine has the following components, vol.%: strain L-16v (GKV N 2277) taken in an infecting dose 0.2 ± 0.1 TCD50/cell; aminopeptide 5-8; Eagle medium or Eagle MEM 92-95 medium and a stabilizing agent - the rest. Vaccine shows the enhanced immunogenic activity and provides a possibility of intranasal administration and vaccination of children of age younger 9 months. EFFECT: enhanced effectiveness of vaccine. 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF REGENERATION OF VIRUS MEASLES VACCINE STRAIN | 1995 |
|
RU2088662C1 |
| METHOD OF PREPARING MEASLES VIRUS AND SUPPORTING MEDIUM FOR ITS CULTURING (VARIANTS) | 1996 |
|
RU2129607C1 |
| STRAIN OF MEASLES VIRUS "ORLOV-B" FOR VACCINE PREPARING | 1995 |
|
RU2081912C1 |
| METHOD OF MEASLES VIRUS CULTIVATION | 1994 |
|
RU2053297C1 |
| METHOD OF PREPARING RUBELLA VIRUS AND SUPPORTING NUTRIENT MEDIUM FOR ITS CULTURING (ITS VARIANTS) | 1996 |
|
RU2129608C1 |
| VACCINE STRAIN OF MEASLES VIRUS "ORLOV-D" AND METHOD OF PREPARING VACCINE AGAINST MEASLES | 1999 |
|
RU2173344C2 |
| STRAIN OF HUMAN RHOTAVIRUS FOR PREPARING OF DIAGNOSTIC AND PROPHYLAXIS SERA | 1991 |
|
RU2026345C1 |
| RUBELLA VIRUS STRAIN "ORLOV" (U) FOR OBTAINING MEDICINAL IMMUNO-BIOLOGICAL PREPARATIONS (MIBP) | 2012 |
|
RU2492235C1 |
| METHOD OF OBTAINING LINE ASSOCIATED PAROTITIS-MEASURING VACCINE | 0 |
|
SU604343A1 |
| METHOD OF PREPARING LIVE MEASLES VACCINE FOR ORAL USING AND METHOD OF IMMUNIZATION AGAINST MEASLES | 1997 |
|
RU2133625C1 |
